liver injury
The Silent Threat: Navigating the Complexities of Drug-Induced Liver Injury (DILI)
In the world of pharmacovigilance, few adverse events command as much respect and caution as Drug-Induced Liver Injury (DILI). It is a leading cause of acute liver failure in the Western world and remains the single most frequent safety-related reason for the withdrawal of drugs from the market. Whether you are in clinical development or […]